State Opioid Taxes

Listen to WIG's Podcast on State Opioid Taxes: "How's Your State Handling the Opioid Crisis?"

Women In Government has released a white paper on “State Opioid Taxes: Economic & Health Policy Implications” to analyze the possible ways for states to decrease the impact of the opioid epidemic on the United States. Authored by Alex Brill of Matrix Global Advisors, the paper examines state opioid taxes and calls attention to flaws in the approach.

The Centers for Disease Control and Prevention (CDC) reports that more than 130 Americans die every day from an opioid overdose. The national economic burden of this crisis is more than $500-billion annually when considering the value of lives lost. The impact of the epidemic varies from state-to-state, but all are impacted, with some considering taxation as an option to curb the scourge. “State Opioid Taxes: Economic & Health Policy Implications” explores the effectiveness of opioid taxes in addition to unintended consequences for states.

Brill is the founder and CEO of Matrix Global Advisors. He has testified numerous times before Congress and has served as an expert witness and litigation consultant in both tax and pharmaceutical patent litigations. Brill has written and consulted on small-molecule generic drug competition, drug pricing, Part B reimbursement, generic drug labeling requirements, disease management, and the economic consequences of obesity and obesity mitigation, among other issues. In addition, Alex is currently a resident fellow at the American Enterprise Institute.